Research
A backtest with a 2.8 Sharpe
Your new cross-sectional signal shows a 2.8 Sharpe over twelve years — after you tried 300 feature combinations on the same data.
Signals, capacity and overfitting
Your seat: Systematic research seat, quant fund
You are paid for edge that survives out of sample, real costs and crowding. Every extra specification you try makes your best backtest a little more of a lie.
Systematic research, quant risk and data-driven investing roles.
It works as interview prep: you'll have made the calls an interviewer asks about, and seen what happens when you get them wrong.
Three calls a year. Here's the kind of thing that lands on your desk before your first promotion.
Research
Your new cross-sectional signal shows a 2.8 Sharpe over twelve years — after you tried 300 feature combinations on the same data.
Capacity
Your best strategy earns 14% net at $100m. Market impact analysis suggests it decays to roughly 4% at $900m. Sales has already promised capacity.
Risk
Prime broker data shows your top-decile longs are held by nine similar funds. The strategy has never been more profitable.
Each rank has its own bar for returns and standing. Clear both to move up.